NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Nasdaq SEC CIK 1500198
Follow Neuroone Medical Technologies Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2M +16.3% vs same quarter last year
Net income −$2M −33.7% vs same quarter last year
EPS, diluted −$0.28 −47.4% vs same quarter last year
Operating cash flow −$1.1M +26.1% vs same quarter last year
Revenue by quarter
$272.3K
$3.3M
$1.4M
$1.7M
$2.7M
$2.9M
$1.9M
$2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$9.1M−$3.6M
FY24$3.5M−$12.3M
FY23$2M−$11.9M
FY22$171.2K−$10M
FY21$178.1K−$9.9M
FY20-−$13.6M
FY19-−$6.8M
FY18-−$5.1M
FY17$0−$47.8K
FY16$0−$62.9K
FY15$773−$36.2K
FY14$1.2K−$30.6K
FY13$921−$14K
FY12$5.4K−$27.6K
FY11$1.2K−$6K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2556.5%−46.5%−39.6%
FY2431.3%−344.3%−356.7%
FY2323.4%−612.3%−607.4%
FY22−41.4%−5860.2%−5842%
FY21−54.9%−5735.9%−5584.3%
FY20---
FY19---
FY18---
FY17---
FY16---
FY15-−4646.1%−4688.7%
FY14100%−2009%−2446.3%
FY13100%−1491.1%−1515.7%
FY1260.4%-−511.4%
FY11100%-−517.9%
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$2.9M
FY24−$11.1M
FY23−$13.3M
FY22−$7.8M
FY21−$8.7M
FY20−$3.5M
FY19−$5.5M
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Neuroone Medical Technologies
  • Healthcare median
−6000%−4000%−2000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearNeuroone Medical TechnologiesHealthcare median
FY25−39.6%−30.6%
FY24−356.7%−47%
FY23−607.4%−58%
FY22−5842%−80.4%
FY21−5584.3%−71.8%
FY20-−62.2%
FY19-−46.2%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15−4688.7%−37.8%
FY14−2446.3%−35.5%
FY13−1515.7%−37.1%
FY12−511.4%−29.1%
FY11−517.9%−27.9%